Multiple formulations for analgesic agent delivery via iontophoresis exist currently with approval from the Food and Drug Administration. These include various formulations including patient-activated fentanyl 40 mcg solution, lidocaine hydrochloride (HCl) 2% with epinephrine 1Â to 100000 solution, lidocaine HCl with epinephrine topical iontophoretic patch (10%/0.1%), and lidocaine HCl 4% solution.